Healthequity (HQY) Receivables (2014 - 2026)

Healthequity's Receivables history runs 13 years deep, the most recent figure standing at $122.0 million for Q2 2026.

• In Q2 2026, Receivables rose 4.94% year-over-year to $122.0 million; the TTM figure through Apr 2026 stood at $122.0 million (up 4.94% YoY), while the FY2026 annual figure was $123.7 million, up 4.82% from the prior year.
• Receivables was $122.0 million for Q2 2026 at Healthequity, down from $123.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $123.7 million in Q1 2026 to a low of $86.0 million in Q2 2022.
• Historically, Receivables has averaged $103.6 million across 5 years, with a median of $105.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables grew 21.83% in 2022, then increased 2.38% in 2023.
• A 5-year view of Receivables shows it stood at $87.7 million in 2022, then rose by 9.65% to $96.2 million in 2023, then gained by 10.95% to $106.7 million in 2024, then rose by 4.25% to $111.2 million in 2025, then increased by 9.67% to $122.0 million in 2026.
• The last three Receivables figures came in at $122.0 million (Q2 2026), $123.7 million (Q1 2026), and $111.2 million (Q4 2025), per Business Quant data.